Upcoming Webinars
Regulatory Challenges of Recent Low Endotoxin Recovery Regulatory Queries: Pfizer’s Strategy to Evaluate and Implement Global Changes to Meet Evolving Expectations
Presented by Jody Peraino MS, Principal Scientist, Pfizer, Allen L. Burgenson, Global Subject Matter Expert, Testing Solutions at Lonza
20th March 2026
Navigating the 2025 ISO 10993‑1 Revision
Presented by Elisabet Jamez, Expert Advisory Services team at Nelson Labs and Wouter Buyssens, Scientific Project Manager at Nelson Labs
31st March 2026
Validating rCR on a Microfluidic Platform: A Multi-Matrix Approach
Presented by Meg Provenzano, Global Product Manager for Endotoxin at Veolia
14th April 2026
Automation, Traceability, Reliability: See Our LIMS in Action
Presented by Albane Flocon, Bioinformatics developer at genOway, Christel Merrouche, Head of preclinical processes at genOway and Stéphane Pitout - Director of Professional Sales (SciY)
22nd April 2026
Validation and Implementation of the Monocyte Activation Test as an Alternative Method to the Rabbit Pyrogen Test
Presented by Jonas Van Den Berg, Subject Matter Expert, Pyrogen Testing and Alternative Microbiological Methods at Roche, Luisa Burgmaier, Project Leader, Endotoxin and Pyrogen Testing Group at Microcoat Biotechnologie
13th May 2026
USP General Chapter <665>: Separating Fact from Fiction
Presented by Desmond G Hunt, Senior Principal Scientist at US Pharmacopeia, Dr. Samuel Kikandi, Deputy Director- Principal Engineer at Sanofi
20th May 2026
Roundtable Discussion: Sterility Testing Challenges and Opportunities for ATMPs
Presented by Dr David Roesti, PhD. Microbiology Expert/Senior Technical Steward Manufacturing Science and Technology at Novartis Pharma AG, Irving Ford, Quality Executive, Friedrich von Wintzingerode, Director, ADQC Microbiological Sciences at Roche-Genentech, Sophie Drinkwater, Associate Director in Microbiology at AstraZeneca, Owen Griffin, Sr. Director, Microbiology at Rapid Micro Biosystems and Dr. Joseph Pierquin, Founder and CTO of Redberry, part of Lonza
27th May 2026
Analytical Assessment of Leachables in Biological Drug Products: FDA’s Approach to Reviewing Information and Representative Review Cases
Presented by Andrey Sarafanov, PhD., Principal Investigator at U.S. FDA, Center for Biologics Evaluation and Research
24th September 2026
